Observational studies in the era of randomized trials: finding the balance.
Randomized controlled trials (RCTs) constitute the gold standard for the generation of evidence-based medicine, but may not always be feasible. Furthermore, randomization alone does not guarantee the utility of the research, as evidenced by thousands of uninformative RCTs documented in the literature. Observational studies, including longitudinal, retrospective, and case-control designs, can contribute to the body of evidence in meaningful ways, provide useful information when an RCT is unethical or not feasible, generate hypotheses for RCTs, or provide preliminary work to better inform design of future RCTs. They can also be used to study rare outcomes, risk factors, and side effects, and to examine whether results from RCTs translate into effective treatment in routine practice. Use of modern statistical techniques, both in the study design and in the analysis stage, can improve the usefulness of the evidence obtained from observational studies.
Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, 624 North Broadway Street, HH543, Baltimore, MD 21205, USA.
Renan C
RC
Castillo
Daniel O
DO
Scharfstein
Ellen J
EJ
MacKenzie
D035843:Biomedical Research / Q000379:methods* / Q000706:statistics & numerical data; D016022:Case-Control Studies; D015331:Cohort Studies; D018849:Controlled Clinical Trials as Topic; D003627:Data Interpretation, Statistical; D019317:Evidence-Based Medicine; D006801:Humans; D019370:Observation; D019637:Orthopedic Procedures; D016032:Randomized Controlled Trials as Topic; D012107:Research Design